Pain in Osteoarthritis

Veterinary Clinics of North America - Equine Practice

Volumn 26, Issue 3, 2010, Pages 619-642

  van Weeren, P René ^a   de Grauw, Janny C ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Articular cartilage; Joint pain; Osteoarthritis; Pharmacologic management of joint pain

Indexed keywords

ANALGESIC AGENT; ANTIINFLAMMATORY AGENT;

ANIMAL; ANIMAL DISEASE; ARTICULAR CARTILAGE; HORSE; HORSE DISEASE; INTRAARTICULAR DRUG ADMINISTRATION; JOINT; OSTEOARTHRITIS; PAIN; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CARTILAGE, ARTICULAR; HORSE DISEASES; HORSES; INJECTIONS, INTRA-ARTICULAR; JOINTS; OSTEOARTHRITIS; PAIN;

EID: 78149251503     PISSN: 07490739     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cveq.2010.07.007     Document Type: Review

References (140)

1. Leigh J.P., Seavey W., Leistikow B. Estimating the costs of job related arthritis. J Rheumatol 2001, 28:1647-1654.
2. Bitton R. The economic burden of osteoarthritis. Am J Manag Care 2009, 15(Suppl 8):S230-S235.
3. Le Pen J., Reygrobellet C., Gérentes I. Financial costs of osteoarthritis in France. The " COART" France study. Joint Bone Spine 2005, 72:567-570.
4. Frisbie D.D. Synovial joint biology and pathology. Equine surgery 2006, 1037-1055. Saunders, St. Louis (MO). 3rd edition. J.A. Auer, J.A. Stick (Eds.).
5. Samuels J., Krasnokutsky S., Abramson S.B. Osteoarthritis. A tale of three tissues. Bull NYU Hosp Jt Dis 2008, 66:244-250.
6. Saris D.B., Dhert W.J., Verbout A.J. Joint homeostasis. The discrepancy between old and fresh defects in cartilage repair. J Bone Joint Surg Br 2003, 85:1067-1076.
7. Todhunter R.J. General principles of joint pathobiology. Joint disease in the horse 1996, 1-28. Saunders, Philadelphia. C.W. McIlwraith, G.W. Trotter (Eds.).
8. Palmer J.L., Bertone A.L. Joint biomechanics in the pathogenesis of traumatic arthritis. Joint disease in the horse 1996, 104-119. WB Saunders, Philadelphia. C.W. McIlwraith, G.W. Trotter (Eds.).
9. Kempson G.E. The mechanical properties of articular cartilage. The joints and synovial fluid, vol. 2 1980, 177-238. Academic Press, New York. L. Sokoloff (Ed.).
10. Jurvelin J., Säämänen A.M., Arokoski J., et al. Biomechanical properties of canine knee articular cartilage as related to matrix proteoglycans and collagen. Eng Med 1988, 17:147-162.
11. Eyre D.R., Wu J.J. Collagen structure and cartilage matrix integrity. J Rheumatol Suppl 1995, 43:82-85.
12. Van Weeren P.R., Brama P.A. Physiology and pathology of the equine joint. Pferdeheilk 2001, 17:307-318.
13. Branch M.V., Murray R.C., Dyson S.J., et al. Is there a characteristic distal tarsal subchondral bone plate thickness pattern in horses with no history of hindlimb lameness?. Equine Vet J 2005, 37:450-455.
14. Knox P., Levick J.R., McDonald J.N. Synovial fluid. Its mass, macromolecular content, and pressure in major limbs of the rabbit. Q J Exp Physiol 1988, 73:33-36.
15. Van Weeren P.R., Firth E.C. Future tools for early diagnosis and monitoring of musculoskeletal injury: biomarkers and CT. Vet Clin North Am Equine Pract 2008, 24:153-175.
16. Brandt K.D., Dieppe P., Radin E. Etiopathogenesis of osteoarthritis. Med Clin North Am 2009, 93:1-24.
17. McIlwraith C.W. General pathobiology of the joint and response to injury. Joint disease in the horse 1996, 40-70. WB Saunders, Philadelphia. C.W. McIlwraith, G.W. Trotter (Eds.).
18. Attur M.G., Dave M., Akamatsu M., et al. Osteoarthritis or osteoarthrosis: the definition of inflammation becomes a semantic issue in the genomic era of molecular medicine. Osteoarthritis Cartilage 2002, 10:1-4.
19. Loeser R.F. Molecular mechanisms of cartilage destruction: mechanics, inflammatory mediators, and aging collide. Arthritis Rheum 2006, 54:1357-1360.
20. Trotter G.W., McIlwraith C.W. Clinical features and diagnosis of equine joint disease. Joint disease in the horse 1996, 120-145. WB Saunders, Philadelphia. C.W. McIlwraith, G.W. Trotter (Eds.).
21. Verzijl N., DeGroot J., Thorpe S.R., et al. Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem 2000, 50:39027-39031.
22. Kuettner K., Goldberg V.M. Introduction. Osteoarthritic disorders 1995, xxi-xxv. American Association of Orthopedic Surgeons, Rosemont (IL). K. Kuettner, V.M. Goldberg (Eds.).
23. Goldring M.B., Goldring S.R. Osteoarthritis. J Cell Physiol 2007, 213:626-634.
24. Raffa R.B. Mechanism of action of analgesics used to treat osteoarthritis pain. Rheum Dis Clin North Am 2003, 29:733-745.
25. Caron J.P. Neurogenic factors in joint pain and disease pathogenesis. Joint disease in the horse 1996, 71-80. WB Saunders, Philadelphia. C.W. McIlwraith, G.W. Trotter (Eds.).
26. Niissalo S., Hukkanen M., Imai S., et al. Neuropeptides in experimental and degenerative arthritis. Ann N Y Acad Sci 2002, 966:384-399.
27. Haegerstrand A., Dalsgaard C.J., Jonzon B., et al. Calcitonin gene-related peptide stimulates proliferation of human endothelial cells. Proc Natl Acad Sci U S A 1990, 87:1299-1303.
28. Schuelert N., McDougall J.J. Electrophysiological evidence that the vasoactive intestinal peptide receptor antagonist VIP6-28 reduces nociception in an animal model of osteoarthritis. Osteoarthritis Cartilage 2006, 14:1155-1162.
29. Gwilym S.E., Keltner J.R., Warnaby C.E., et al. Psychophysical and functional imaging evidence supporting the presence of central sensitization in a cohort of osteoarthritis patients. Arthritis Rheum 2009, 61(9):1226-1234.
30. Calich A.L., Domiciano D.S., Fuller R. Osteoarthritis: can anti-cytokine therapy play a role in treatment?. Clin Rheumatol 2010, 29:451-455.
31. Goldring S.R., Goldring M.B. The role of cytokines in cartilage matrix degradation in osteoarthritis. Clin Orthop Relat Res 2004, 427(Suppl):S27-S36.
32. Pettipher E.R. Pathogenesis and treatment of chronic arthritis. Sci Prog 1989, 73:521-534.
33. Trumble T.N., Billinghurst R.C., McIlwraith C.W. Correlation of prostaglandin E2 concentrations in synovial fluid with ground reaction forces and clinical variables for pain or inflammation in dogs with osteoarthritis induced by transection of the cruciate ligament. Am J Vet Res 2004, 65:1269-1275.
34. Lascelles B.D., King S., Roe S., et al. Expression and activity of COX-1 and 2 and 5-LOX in joint tissues from dogs with naturally occurring coxofemoral joint osteoarthritis. J Orthop Res 2009, 27:1204-1208.
35. Benito M.J., Veale D.J., FitzGerald O., et al. Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis 2005, 64:1263-1267.
36. De Grauw J.C., van de Lest C.H., van Weeren R., et al. Arthrogenic lameness of the fetlock: synovial fluid markers of inflammation and cartilage turnover in relation to clinical joint pain. Equine Vet J 2006, 38:305-311.
37. Guerrero A.T., Verri W.A., Cunha T.M., et al. Involvement of LTB4 in zymosan-induced joint nociception in mice: participation of neutrophils and PGE2. J Leukoc Biol 2008, 83:122-130.
38. De Grauw J.C., Brama P.A., Wiemer P., et al. Cartilage-derived biomarkers and lipid mediators of inflammation in horses with osteochondritis dissecans of the distal intermediate ridge of the tibia. Am J Vet Res 2006, 67:1156-1162.
39. Suzuki T., Segami N., Nishimura M., et al. Bradykinin expression in synovial tissues and synovial fluids obtained from patients with internal derangement of the temporomandibular joint. Cranio 2003, 21:265-270.
40. Bouloux G.F. Temporomandibular joint pain and synovial fluid analysis: a review of the literature. J Oral Maxillofac Surg 2009, 67:2497-2504.
41. Fortier L.A., Nixon A.J. Distributional changes in substance P nociceptive fiber patterns in naturally osteoarthritic articulations. J Rheumatol 1997, 24:524-530.
42. Kirker-Head C.A., Chandna V.K., Agarwal R.K., et al. Concentrations of substance P and prostaglandin E2 in synovial fluid of normal and abnormal joints of horses. Am J Vet Res 2000, 61:714-718.
43. Dray A. Kinins and their receptors in hyperalgesia. Can J Physiol Pharmacol 1997, 75:704-712.
44. Meini S., Maggi C.A. Knee osteoarthritis: a role for bradykinin?. Inflamm Res 2008, 57:351-361.
45. Charo I.F., Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006, 354:610-621.
46. Miller R.J., Hosung J., Bhangoo S.K., et al. Cytokine and chemokine regulation of sensory neuron function. Handb Exp Pharmacol 2009, 194:417-449.
47. Van Loon J.P., de Grauw J.C., van Dierendonck M., et al. Intra-articular opioid analgesia is effective in reducing joint pain and inflammation in an equine LPS induced synovitis model. Equine Vet J 2010, 42(5):412-419.
48. Landoni M.F., Foot R., Frean S., et al. Effects of flunixin, tolfenamic acid, R(-) and S(+) ketoprofen on the response of equine synoviocytes to lipopolysaccharide stimulation. Equine Vet J 1996, 28:468-475.
49. De Grauw J.C., van de Lest C.H., Brama P.A., et al. In vivo effects of meloxicam on inflammatory mediators, MMP activity and cartilage biomarkers in equine joints with acute synovitis. Equine Vet J 2009, 41:693-699.
50. Chen Y.F., Jobanputra P., Barton P., et al. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, vadecoxib and lumiracaxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. Health Technol Assess 2008, 12. 1-278.
51. Goodrich L.R., Nixon A.J. Medical treatment of osteoarthritis in the horse-a review. Vet J 2006, 171:51-69.
52. Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study. JAMA 1986, 256:1749-1757.
53. National Toxicology Program NTP Toxicology and Carcinogenesis Studies of Phenylbutazone (CAS No. 50-33-9) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Natl Toxicol Program Tech Rep Ser 1990, 367:1-205.
54. Dodman N., Blondeau N., Marini A.M. Association of phenylbutazone usage with horses bought for slaughter: a public health risk. Food Chem Toxicol 2010, 48(5):1270-1274.
55. Frisbie D.D., McIlwraith C.W., Kawcak C.E., et al. Evaluation of topically administered liposomal cream for treatment of horses with experimentally induced arthritis. Am J Vet Res 2009, 70:210-215.
56. Owens J.G., Kamerling S.G., Stanton S.R., et al. Effects of pretreatment with ketoprofen and phenylbutazone on experimentally induced synovitis in the horse. Am J Vet Res 1996, 57:866-874.
57. Johnson C.B., Taylor P.M., Young S.S., et al. Postoperative analgesia using phenylbutazone, flunixin or carprofen in horses. Vet Rec 1993, 133:336-338.
58. Erkert R.S., MacAllister C.G., Payton M.E., et al. Use of force plate analysis to compare the analgesic effects of intravenous administration of phenylbutazone and flunixin meglumine in horses with navicular syndrome. Am J Vet Res 2005, 66(2):284-288.
59. Beluche L.A., Bertone A.L., Anderson D.E., et al. Effects of oral administration of phenylbutazone to horses on in vitro articular cartilage metabolism. Am J Vet Res 2001, 62:1916-1921.
60. Frean S.P., Cambridge H., Lees P. Effects of anti-arthritic drugs on proteoglycan synthesis by equine cartilage. J Vet Pharmacol Ther 2002, 25:289-298.
61. Jolly W.T., Whittem T., Jolly A.C., et al. The dose-related effects of phenylbutazone and a methylprednisolone acetate formulation (Depo-Medrol) on cultured explants of equine carpal articular cartilage. J Vet Pharmacol Ther 1995, 18:429-437.
62. Fradette M.E., Céleste C., Beauchamp R.H., et al. Effects of continuous oral administration of phenylbutazone on biomarkers of cartilage and bone metabolism in horses. Am J Vet Res 2007, 68:128-133.
63. Owens J.G., Clark T.P. Analgesia. Vet Clin North Am Equine Pract 1999, 15(3):705-723.
64. Houdeshell J.W., Hennessy P.W. A new non-steroidal, anti-inflammatory analgesic for horses. J Equine Med Surg 1977, 1:57-63.
65. Moses V.S., Hardy J., Bertone A.L., et al. Effects of anti-inflammatory drugs on lipopolysaccharide-challenged and -unchallenged equine synovial explants. Am J Vet Res 2001, 62:54-60.
66. Trillo M.A., Soto G., Gunson D.E. Flunixin toxicity in a pony. Equine Pract 1984, 6:21-29.
67. Armstrong S., Lees P. Effects of carprofen (R and S enantiomers and racemate) on the production of IL-1, IL-6 and TNF-alpha by equine chondrocytes and synoviocytes. J Vet Pharmacol Ther 2002, 25:145-153.
68. Frean S.P., Abraham L.A., Lees P. In vitro stimulation of equine articular cartilage proteoglycan synthesis by hyaluronan and carprofen. Res Vet Sci 1999, 67:183-190.
69. Armstrong S., Lees P. Effects of R and S enantiomers and a racemic mixture of carprofen on the production and release of proteoglycan and prostaglandin E2 from equine chondrocytes and cartilage explants. Am J Vet Res 1999, 60:98-104.
70. May S.A., Lees P. Nonsteroidal anti-inflammatory drugs. Joint disease in the horse 1996, 223-237. WB Saunders, Philadelphia. C.W. McIlwraith, G.W. Trotter (Eds.).
71. Owens J.G., Kamerling S.G., Barker S.A. Pharmacokinetics of ketaprofen in healthy horses and horses with acute synovitis. J Vet Pharmacol Ther 1995, 18:187-195.
72. Owens J.G., Kamerling S.G., Stanton S.R., et al. Effects of ketoprofen and phenylbutazone on chronic hoof pain and lameness in the horse. Equine Vet J 1995, 27:296-300.
73. MacAllister C.G., Morgan S.J., Borne A.T., et al. Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses. J Am Vet Med Assoc 1993, 202(1):71-77.
74. Lees P., May S.A., Hoeijmakers M., et al. A pharmacodynamic and pharmacokinetic study with vedaprofen in an equine model of acute nonimmune inflammation. J Vet Pharmacol Ther 1999, 22:96-106.
75. Toutain P.L., Cester C.C. Pharmacokinetic-pharmacodynamic relationships and dose response to meloxicam in horses with induced arthritis in the right carpal joint. Am J Vet Res 2004, 65:1533-1541.
76. Beretta C., Caravaglia G., Cavalli M. COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis. Pharmacol Res 2005, 52:302-306.
77. Dirikolu L., Woods E., Boyles J., et al. Nonsteroidal anti-inflammatory agents and musculoskeletal injuries in thoroughbred racehorses in Kentucky. J Vet Pharmacol Ther 2009, 32:271-279.
78. Jones E.W., Hamm D. Comparative efficacy of PBZ and naproxen in induced equine myositis. J Equine Med Surg 1978, 2:341-347.
79. Trumble T.N. The use of neutraceuticals for osteoarthritis in horses. Vet Clin North Am Equine Pract 2005, 21:575-597.
80. Richardson D.W., Loinaz R. An evidence-based approach to selected joint therapies in the horse. Vet Clin North Am Equine Pract 2007, 23:443-460.
81. Denoix J.M., Thibaud D., Riccio B. Tiludronate as a new therapeutic agent in the treatment of navicular disease: a double-blind placebo-controlled clinical trial. Equine Vet J 2003, 35:407-413.
82. Coudry V., Thibaud D., Riccio B., et al. Efficacy of tiludronate in the treatment of horses with signs of pain associated with osteoarthritic lesions of the thoracolumbar vertebral column. Am J Vet Res 2007, 68:329-337.
83. White G.W., Stites T., Jones W., et al. Efficacy of intramuscular chondroitin sulfate and compounded acetyl-d-glucosamine in a positive controlled study of equine carpitis. Proc Am Assoc Equine Pract 2004, 50:264-269.
84. Frisbie D.D., Kawcak C.E., McIlwraith C.W., et al. Evaluation of the effect of extracorporeal shock wave treatment on experimentally induced osteoarthritis in middle carpal joints of horses. Am J Vet Res 2009, 70:449-454.
85. Trotter G.W., Yovich J.V., McIlwarith C.W., et al. Effects of intramuscular polysulfated glycosaminoglycans on chemical and physical defects in equine articular cartilage. Can J Vet Res 1989, 53:224-230.
86. Popot M.A., Bonnaire Y., Guéchot J., et al. Hyaluronan in horses: physiological production rate, plasma and synovial fluid concentration in control conditions and following sodium hyaluronate administration. Equine Vet J 2004, 36:482-487.
87. Peña Ede L., Sala S., Rovira J.C., et al. Elastoviscous substances with analgesic effects in joint pain reduce stretch-activated ion channel activity in vitro. Pain 2002, 99:501-508.
88. Kawcak C.E., Frisbie D.D., Trotter G.W., et al. Effects of intravenous administration of sodium hyaluronate on carpal joints in exercising horses after arthroscopic surgery and osteochondral fragmentation. Am J Vet Res 1997, 58:1132-1140.
89. Hollander J.L., Brown E.M., Jessar R.A., et al. Hydrocortisone and cortisone injected into arthritic joints; comparative effects of and use of hydrocortisone as a local antiarthritic agent. J Am Med Assoc 1951, 147:1629-1635.
90. Van Pelt R.W. Clinical and synovial fluid response to intrasynovial injection of 6alpha-methylprednisolone acetate into horses and cattle. J Am Vet Med Assoc 1963, 143:738-748.
91. Shalom-Barak T., Quach J., Lotz M. Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinase and NF-kappaB. J Biol Chem 1998, 273:467-473.
92. Garvican E.R., Vaughan-Thomas A., Redmond C., et al. MMP-mediated collagen breakdown induced by activated protein C in equine cartilage is reduced by corticosteroids. J Orthop Res 2010, 28:370-378.
93. Kydd A.S., Reno C.R., Tsoa H.W., et al. Early inflammatory arthritis in the rabbit: the influence of intraarticular and systemic corticosteroids on mRNA levels in connective tissues of the knee. J Rheumatol 2007, 34:130-139.
94. Di Rosa R.J., Flower F., Hirata L., et al. Nomenclature announcement. Anti-phospholipase proteins. Prostaglandins 1984, 28:441-442.
95. Habib G.S., Saliba W., Nashashibi M. Local effects of intra-articular corticosteroids. Clin Rheumatol 2010, 29:347-356.
96. Bellamy N., Campbell J., Robinson V., et al. Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2002, 2. CD005328.
97. Chandler G.N., Wright V. Deleterious effect of intra-articular hydrocortisone. Lancet 1958, 7048:661-663.
98. Salter R.B., Gross A., Hamilton Hall J. Hydrocortisone arthropathy-an experimental investigation. Can Med Assoc J 1967, 97:374-377.
99. Raynauld J.P., Buckland-Wright C., Ward R., et al. Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomised, double-blind, placebo-controlled trial. Arthritis Rheum 2003, 48:370-377.
100. Parikh J.R., Houpt J.B., Jacobs S., et al. Charcot's arthropathy of the shoulder following intraarticular corticosteroid injections. J Rheumatol 1993, 20:885-887.
101. Todhunter R.J., Fubini S.L., Vernier-Singer M., et al. Acute synovitis and intra-articular methylprednisolone acetate in ponies. Osteoarthritis Cartilage 1998, 6:94-105.
102. MacLeod J.N., Fubini S.L., Gu D.N., et al. Effect of synovitis and corticosteroids on transcription of cartilage matrix proteins. Am J Vet Res 1998, 59:1021-1026.
103. Pal B., Morris J. Perceived risks of joint infection following intra-articular corticosteroid injections: a survey of rheumatologists. Clin Rheumatol 1999, 18:264-265.
104. Hollander J.L. Intrasynovial corticosteroid therapy in arthritis. Md State Med J 1970, 19:62-66.
105. Farquhar T., Todhunter R.J., Fubini S.L., et al. Effect of methylprednisolone and mechanical loading on canine articular cartilage in explant culture. Osteoarthritis Cartilage 1996, 4:55-62.
106. Todhunter R.J., Fubini S.L., Wootton J.A., et al. Effect of methylprednisolone acetate on proteoglycan and collagen metabolism of articular cartilage explants. J Rheumatol 1996, 23:1207-1213.
107. Houdeshell J.W. Field trials of a new long-acting corticosteroid in the treatment of equine athropathies. Vet Med Small Anim Clin 1969, 64:782-784.
108. Foland J.W., McIlwraith C.W., Trotter G.W., et al. Effect of betamethasone and exercise on equine carpal joints with osteochondral fragments. Vet Surg 1994, 23:369-376.
109. Kay A.T., Bolt D.M., Ishihara A., et al. Anti-inflammatory and analgesic effects of intra-articular injection of triamcinolone acetonide, mepivacaine hydrochloride, or both on lipopolysaccharide-induced lameness in horses. Am J Vet Res 2008, 69:15646-15654.
110. Richardson D.W., Dodge G.R. Dose-dependent effects of corticosteroids on the expression of matrix-related genes in normal and cytokine-treated articular chondrocytes. Inflamm Res 2003, 52:39-49.
111. Frisbie D.D., Kawcak C.E., Trotter G.W., et al. Effects of triamcinolone acetonide on an in vivo equine osteochondral fragment exercise model. Equine Vet J 1997, 29:349-359.
112. Céleste C., Ionescu M., Poole R.A., et al. Repeated intraarticular injections of triamcinolone acetonide alter cartilage matrix metabolism measured by biomarkers in synovial fluid. J Orthop Res 2005, 23:602-610.
113. Stein C., Comisel K., Haimerl E., et al. Analgesic effect of intraarticular morphine after arthroscopic knee surgery. N Engl J Med 1991, 325:1123-1126.
114. Gupta A., Bodin L., Holmström B., et al. A systematic review of the peripheral analgesic effects of intraarticular morphine. Anesth Analg 2001, 93:761-770.
115. Rosseland L.A. No evidence for analgesic effect of intra-articular morphine after knee arthroscopy: a qualitative systematic review. Reg Anesth Pain Med 2005, 30:83-98.
116. Pascoe P.J. Opioid analgesics. Vet Clin North Am Small Anim Pract 2000, 30:757-772.
117. Santos L.C., de Moraes A.N., Saito M.E. Effects of intraarticular ropivacaine and morphine on lipopolysaccharide-induced synovitis in horses. Vet Anaesth Analg 2009, 36:280-286.
118. Lindegaard C., Gleerup K.B., Thomsen M.H., et al. Anti-inflammatory effects of intra-articular administration of morphine in horses with experimentally induced synovitis. Am J Vet Res 2010, 71:69-75.
119. Lindegaard C., Thomsen M.H., Larsen S., et al. Analgesic efficacy of intra-articular morphine in experimentally induced radiocarpal synovitis in horses. Vet Anaesth Analg 2010, 37:171-185.
120. Likar R., Schäfer M., Paulak F., et al. Intraarticular morphine analgesia in chronic pain patients with osteoarthritis. Anesth Analg 1997, 84:1313-1317.
121. Fine P.G., Mahajan G., McPherson M.L. Long-acting opioids and short-acting opioids: appropriate use in chronic pain management. Pain Med 2009, 10(Suppl 2):S79-S88.
122. Caron J.P. Intra-articular injections for joint disease in horses. Vet Clin North Am Equine Pract 2005, 21:559-573.
123. Moskowitz R.W. Hyaluronic acid supplementation. Curr Rheumatol Rep 2000, 2:466-471.
124. Lo G.H., LaValley M., McAlindon T., et al. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA 2003, 290:3115-3121.
125. Yates A.C., Stewart A.A., Byron C.R., et al. Effects of sodium hyaluronate and methylprednisolone acetate on proteoglycan metabolism in equine articular chondrocytes treated with interleukin-1. Am J Vet Res 2006, 67:1980-1986.
126. Doyle A.J., Stewart A.A., Constable P.D., et al. Effects of sodium hyaloronate and methylprednisolone acetate on proteoglycan synthesis in equine articular cartilage explants. Am J Vet Res 2005, 66:48-53.
127. Eastman T., Panus P.C., Honnas C.M., et al. Cathodic iontophoresis of ketoprofen over the equine middle carpal joint. Equine Vet J 2001, 33:614-616.
128. Frisbie D.D., Ghivizzani S.C., Robbins P.D., et al. Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene. Gene Ther 2002, 9:12-20.
129. Goodrich L.R., Brower-Toland B.D., Warnick L., et al. Direct adenovirus-mediated IGF-1 gene transduction of synovium induces persisting synovial fluid IGF-1 ligand elevations. Gene Ther 2006, 13:1253-1262.
130. Malone E.D. Managing chronic arthritis. Vet Clin North Am Equine Pract 2002, 18:411-437.
131. Auer JA. Arthrodesis techniques. In: Equine surgery, editors. Auer JA, Stick JA. 3rd edition. St. Louis (MO): Saunders; 2006. p. 1073-86.
132. Jones P., Delco M., Beard W., et al. A limited surgical approach for pastern arthrodesis in horses with severe osteoarthritis. Vet Comp Orthop Traumatol 2009, 22:303-308.
133. Shoemaker R.W., Allen A.L., Richardson C.E., et al. Use of intra-articular administration of ethyl alcohol for arthrodesis of the tarsometatarsal joint in healthy horses. Am J Vet Res 2006, 67:850-857.
134. Burch F.X., Tarro J.N., Greenberg J.J., et al. Evaluating the benefits of patterned stimulation in the treatment of osteoarthritis of the knee: a multi-center, randomized single-blind, controlled study with an independent masked evaluator. Osteoarthritis Cartilage 2008, 16:865-872.
135. Rutjes A.W., Nüesch E., Sterchi R., et al. Transcutaneous electrostimulation for osteoarthritis of the knee. Cochrane Database Syst Rev 2009, 4. CD002823.
136. Revenaugh M.S. Extracorporeal shock wave therapy for treatment of osteoarthritis in the horse: clinical applications. Vet Clin North Am Equine Pract 2005, 21:609-625.
137. Frisbie D.D., Kawcak C.E., McIlwraith C.W. Evaluation of the effect of extracorporeal shock wave treatment on experimentally induced osteoarthritis in middle carpal joints of horses. Am J Vet Res 2009, 70:449-454.
138. Mayer-Wagner S., Ernst J., Maier M., et al. The effect of high-energy extracorporeal shock waves on hyaline cartilage of adult rats in vivo. J Orthop Res 2010, 28(8):1050-1056.
139. Ahmed T.A., Hincke M.T. Strategies for articular cartilage lesion repair and functional restoration. Tissue Eng Part B Rev 2010, 16(3):305-329.
140. Dray A., Read S.J. Future targets to control osteoarthritis pain. Arthritis Res Ther 2007, 9:212.